or Try an Advanced Search...

    Technical Analysis for BNTX - BioNTech SE

    Grade Last Price % Change Price Change
    D 90.35 -0.29% -0.26
    BNTX closed down 2.55 percent on Friday, May 17, 2024, on 78 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    7 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Flat Down
    Historical BNTX trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish -0.29%
    180 Bearish Setup Bearish Swing Setup -0.29%
    Gapped Up Strength -2.01%
    NR7 Range Contraction -2.56%
    Narrow Range Bar Range Contraction -2.56%
    Gapped Up Strength -2.56%
    Inside Day Range Contraction -1.44%
    Crossed Above 50 DMA Bullish -1.86%
    Pocket Pivot Bullish Swing Setup -1.86%
    Upper Bollinger Band Walk Strength -1.86%
    Older End-of-Day Signals for BNTX ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Resistance 18 minutes ago
    50 DMA Resistance 23 minutes ago
    Rose Above 50 DMA 29 minutes ago
    20 DMA Support 35 minutes ago
    Bearish 180 Entry about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    BNTX Chart by TradingView
    Basic chart:

    Profile

    BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches. The firm develops and manufactures biomarker-based in vitro diagnostic devices (IVDD) and commercializes products. It offers drug discovery services for therapeutic areas including infectious diseases, allergies and autoimmune disorders. The company was founded by Christopher Huber, Özlem Türeci and Ugur Sahin in 2008 and is headquartered in Mainz, Germany.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Clinical Medicine Disease Immunology Infectious Diseases Drug Discovery Vaccines Biomarkers Allergy Autoimmunity In Vitro Autoimmune Disorders Immune Disorders Allergies Diagnostic Devices In Vitro Diagnostic Device

    Is BNTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 17 European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
    May 17 Update: Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
    May 17 Market Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech
    May 17 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
    May 14 Evercore says biotech ‘winter is finally thawing’
    May 11 We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
    May 8 BioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
    May 7 BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
    May 7 BioNTech reports net loss of €315.1m in Q1 2024
    May 7 Q1 2024 BioNTech SE Earnings Call
    See more BNTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 125.83
    52 Week Low 85.2129
    Average Volume 602,378
    200-Day Moving Average 99.70
    50-Day Moving Average 90.67
    20-Day Moving Average 90.45
    10-Day Moving Average 91.89
    Average True Range 2.26
    RSI (14) 49.49
    ADX 16.34
    +DI 21.53
    -DI 17.37
    Chandelier Exit (Long, 3 ATRs) 88.51
    Chandelier Exit (Short, 3 ATRs) 92.39
    Upper Bollinger Bands 94.65
    Lower Bollinger Band 86.26
    Percent B (%b) 0.52
    BandWidth 9.28
    MACD Line 0.66
    MACD Signal Line 0.48
    MACD Histogram 0.1834
    Fundamentals Value
    Market Cap 21.54 Billion
    Num Shares 238 Million
    EPS 12.15
    Price-to-Earnings (P/E) Ratio 7.46
    Price-to-Sales 3.38
    Price-to-Book 1.03
    PEG Ratio 0.04
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 94.01
    Resistance 3 (R3) 94.36 93.58 93.44
    Resistance 2 (R2) 93.58 92.71 93.40 93.25
    Resistance 1 (R1) 92.10 92.18 91.71 91.74 93.06
    Pivot Point 91.32 91.32 91.12 91.14 91.32
    Support 1 (S1) 89.83 90.45 89.44 89.48 88.16
    Support 2 (S2) 89.05 89.92 88.87 87.97
    Support 3 (S3) 87.57 89.05 87.78
    Support 4 (S4) 87.21